Standard Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10
Closed -$1K 61
2022
Q3
$1K Hold
10
﹤0.01% 437
2022
Q2
$1K Buy
+10
New +$1K 0.01% 190
2022
Q1
Sell
-18
Closed -$2K 98
2021
Q4
$2K Buy
+18
New +$2K 0.02% 185
2021
Q1
Sell
-18
Closed -$2K 623
2020
Q4
$2K Buy
+18
New +$2K ﹤0.01% 388